PL EN


Preferences help
enabled [disable] Abstract
Number of results
2002 | 50 | 6 | 409-418
Article title

Experimental therapies for psoriasis

Content
Title variants
Languages of publication
EN
Abstracts
EN
There is a high medical need for better therapies for psoriasis. Based on new insight into the pathophysiology of this frequent immune disease, a number of novel systemic immunomodulatory therapies are currently in clinical development. These include approaches targeting antigen presentation and costimulation, T cell activation and leukocyte adhesion, action of proinflammatory mediators, and modulating the cytokine balance. Although mainly only preliminary data are available so far, these trials contribute to a further understanding of the disease and will eventually lead to new therapeutic options for psoriasis. Moreover, since psoriasis can be considered as a visible model disease for T cell-mediated disorders characterized by a type 1 cytokine pattern in general, such approaches may have impact for other immune disorders as well. Here we review the rationale and the initial clinical data of these important recent experimental therapies.
Keywords
References
Document Type
REVIEW
Publication order reference
K. Asadullah, Corporate Research Business Area Dermatology, Schering AG, D-13342 Berlin, Germany
YADDA identifier
bwmeta1.element.element-from-psjc-5d5e1b8a-739a-3824-b653-c7b5ba961ecb
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.